Modus Therapeutics publishes interim report for the third quarter 2021
STOCKHOLM, SWEDEN - 18 November 2021: Modus Therapeutics Holding AB (”Modus Therapeutics”) hereby publishes an interim report for the third quarter 2021. The interim report is available as an attached document and on the company's website (www.modustx.com). Below is a summary of the interim report.The third quarter in figures · The loss after tax amounted to TSEK 4 441 (697). · The loss per share amounted to SEK 0,30 (0,12) · The cash flow from current operations was negative in the amount of TSEK 4 226 (942) The first nine-months in figures · The loss after tax amounted